期刊
NATURE REVIEWS MOLECULAR CELL BIOLOGY
卷 13, 期 11, 页码 713-726出版社
NATURE PORTFOLIO
DOI: 10.1038/nrm3448
关键词
-
类别
资金
- Dutch government [FES0908]
- EU (HPSCLQT) [29999]
Worldwide increases in life expectancy have been paralleled by a greater prevalence of chronic and age-associated disorders, particularly of the cardiovascular, neural and metabolic systems. This has not been met by commensurate development of new drugs and therapies, which is in part owing to the difficulty in modelling human diseases in laboratory assays or experimental animals. Patient-specific induced pluripotent stem (iPS) cells are an emerging paradigm that may address this. Reprogrammed somatic cells from patients are already applied in disease modelling, drug testing and drug discovery, thus enabling researchers to undertake studies for treating diseases 'in a dish', which was previously inconceivable.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据